Skip to main content
. 2022 Jan 4;49(6):1970–1984. doi: 10.1007/s00259-021-05627-2

Fig. 1.

Fig. 1

Trial profile. The dashed line indicates the patients who deviated from the treatment advise per protocol. NIFTP, non-invasive follicular thyroid neoplasm with papillary-like nuclear features. FT-UMP-OV, follicular tumour of uncertain malignant potential, Hürthle cell type. *: a specification of reasons for ineligibility is provided in Supplementary Table 2